MedTrace Logo

Observational Study on Contraception With Essure in France

NCT02510443 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2644

Last updated 2017-09-13

No results posted yet for this study

Summary

Using a very broad survey, the objective is to confirm the effectiveness of the Essure method, and to obtain more information on the conditions of use as well as on the methods used during the 3-month check-up, as well as the 12-month, 24-month and 5-year follow-up on patients.

Conditions

  • Contraception

Interventions

DEVICE

ESS305 (Essure, BAY1454032)

Bilateral insert placement

Sponsors & Collaborators

  • Hôpital André Mignot Centre Hospitalier de Versailles

    collaborator UNKNOWN

  • Bayer

    lead INDUSTRY

Principal Investigators

  • Bayer Study Director · Bayer

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2008-06-23
Primary Completion
2016-09-29
Completion
2016-11-25

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02510443 on ClinicalTrials.gov